The global chronic obstructive pulmonary disease (COPD) therapeutics market is set to experience significant growth, with a market value of USD 12,144.1 million in 2023. According to recent industry projections, the market is anticipated to reach USD 20,035.5 million by 2033, registering a compound annual growth rate (CAGR) of 5.1% over the forecast period. The …